T. Ando

REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients

E. Oki, T. Yamanaka, J. Furuse, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Relationships between the onset of pustulosis palmaris et plantaris, periodontitis and bacterial heat shock proteins.

T. Kato, K. Okuda, K. Ishihara, 2000, Oral microbiology and immunology.

Detection of heat shock proteins but not superantigen by isolated oral bacteria from patients with Behcet's disease.

T. Kato, K. Okuda, K. Ishihara, 2005, Oral microbiology and immunology.

REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients.

E. Oki, T. Yamanaka, J. Furuse, 2019 .

REVERCE: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan: Quality of life analysis.

E. Oki, T. Yamanaka, J. Furuse, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.